The collective results of this study demonstrated that gain-of-function mutations in KRAS play a crucial role in the initiation of pancreatic neoplasms, but mutant KRAS alone was insufficient to drive invasive characteristics of transforming acinar cells and their duct-like descendants. This evidence concerns the gene KRAS and pancreatic neoplasm.